Nasdaq Shareholder Requirements Just Verified By Adia Med
Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital...
Day: September 8, 2026
Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder
Filament Health's patented, naturally derived psilocybin drug candidate PEX010 has been shipped to Austin Health in Melbourne for PSI-PHY, an...
Altrova Health Signs Exclusive U.S. Distribution Agreement to Launch Its Detection and Wellness Portfolio Across the United States
Company Concurrently Announces Non-Brokered Private Placement to Fund U.S. Commercial LaunchToronto, Ontario--(Newsfile Corp. - September 8, 2026) - Altrova Health...
Ebix Launches Ebix Meridian, a New Operating Platform for U.S. Financial Advisory Firms
New platform brings wealth management, private markets, retirement planning and insurance advisory together with embedded AI capabilities and pricing starting...
Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results
BEIJING, Sept. 8, 2026 /PRNewswire/ -- On September 8, Waterdrop Inc. (NYSE: WDH) released its unaudited financial results for the second...
Israel National Biotech Innovation Center (INBI) Announces Official Launch and the Appointment of Anat Cohen-Dayag, PhD, as Chief Executive Officer of INBI Core
INBI is a transformational hub designed to unlock the value of Israel's world-class biomedical research and accelerate the development of...
Waterdrop Inc. Announces Second Quarter 2026 Unaudited Financial Results and a Cash Dividend
BEIJING, Sept. 8, 2026 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026
SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD),...
Who is the Best Female Cosmetic Surgeon in Florida?
The Best Female Cosmetic Surgeon in Florida Is Dr. Winnie Lee SARASOTA, FL / ACCESS Newswire / September 8, 2026...
Who Does the Best Facelift in Florida?
The Best Facelift in Florida is Done by Dr. Sessa at Sarasota Surgical Arts SARASOTA, FL / ACCESS Newswire /...
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based...
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent...
Custom Health Completes Acquisition of Spencer Health Solutions, Bringing In-Home Medication Dispensing Technology Fully In-House
Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer®...
Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
Sabrina Kuttruff-Coqui appointed Chief Executive Officer, Joachim Koch appointed Chief Scientific and Development Officer and Andreas Muehler joining as Chief...
Equitech-Bio Expands Reagent Portfolio with New IgG Offering and Publication-Backed Product Validation from Bioz
PALO ALTO, CA / ACCESS Newswire / September 8, 2026 / Bioz, Inc., the scientific marketing platform that transforms peer-reviewed...
BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study
VANCOUVER, BC / ACCESS Newswire / September 8, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
Montreal, Quebec--(Newsfile Corp. - September 8, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a...
Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...